DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Tuscaloosa, AL

7 verified pulmonary disease doctors in Tuscaloosa.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Alabama Board of Medical Examiners

Dr. Pedro Lopez, MD

Pulmonary Disease

20 yrs NPPES
NPI 1295796472
701 UNIVERSITY BLVD E, SUITE 711, Tuscaloosa, AL 35401(205) 345-2255
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,821 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,821

Total received

138

Transactions

19

Paying companies

Top paying companies

Mallinckrodt Hospital Products Inc.$609.80
AstraZeneca Pharmaceuticals LP$570.05
GlaxoSmithKline, LLC.$361.41
Grifols USA, LLC$234.57
Boehringer Ingelheim Pharmaceuticals, Inc.$213.94
Regeneron Healthcare Solutions, Inc.$186.77

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 88th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Pedro Lopez do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Ranju Chandrashekariah, MD

Pulmonary Disease

20 yrs NPPES
NPI 1851354385
701 UNIVERSITY BLVD E, SUITE 711, Tuscaloosa, AL 35401(205) 345-2255
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,657 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,657

Total received

83

Transactions

17

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$399.71
GlaxoSmithKline, LLC.$347.84
Mallinckrodt Hospital Products Inc.$212.44
Regeneron Healthcare Solutions, Inc.$186.77
Grifols USA, LLC$141.59
Boehringer Ingelheim Pharmaceuticals, Inc.$101.29

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 84th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Ranju Chandrashekariah do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Jeanne Lipscomb, MD

Pulmonary Disease

20 yrs NPPES
NPI 1790748515
1406 MCFARLAND BLVD N, SUITE 1C, Tuscaloosa, AL 35406(205) 343-0004
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,130 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,130

Total received

53

Transactions

13

Paying companies

Top paying companies

Grifols USA, LLC$227.57
AstraZeneca Pharmaceuticals LP$181.65
GlaxoSmithKline, LLC.$159.99
Takeda Pharmaceuticals U.S.A., Inc.$142.51
Boehringer Ingelheim Pharmaceuticals, Inc.$122.15
Mylan Specialty L.P.$114.41

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 81th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Jeanne Lipscomb do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Narayan Krishnamurthy, MD

Pulmonary Disease

20 yrs NPPES
NPI 1922061712
1406 MCFARLAND BLVD N, SUITE C, Tuscaloosa, AL 35406(205) 343-0004
NPPES public registry
CMS Open Payments· $23.12 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$23.12

Total received

1

Transactions

1

Paying companies

Top paying companies

Grifols USA, LLC$23.12

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is on the lower end — around the 49th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Narayan Krishnamurthy do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Fausto Salinas, MD

Pulmonary Disease

20 yrs NPPES
NPI 1740243443
701 UNIVERSITY BLVD E, SUITE 711, Tuscaloosa, AL 35401(205) 345-2255
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,357 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,357

Total received

124

Transactions

17

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$521.92
Mallinckrodt Hospital Products Inc.$463.14
GlaxoSmithKline, LLC.$308.27
Grifols USA, LLC$191.72
Regeneron Healthcare Solutions, Inc.$186.77
Boehringer Ingelheim Pharmaceuticals, Inc.$151.68

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 87th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Fausto Salinas do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Mohammad Azam, MD

Pulmonary Disease

20 yrs NPPES
NPI 1184688541
701 UNIVERSITY BLVD E, SUITE 711, Tuscaloosa, AL 35401(205) 345-2255
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $8,663 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$8,663

Total received

161

Transactions

23

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$6,106
Mallinckrodt Hospital Products Inc.$722.54
GlaxoSmithKline, LLC.$407.94
Boehringer Ingelheim Pharmaceuticals, Inc.$209.68
Regeneron Healthcare Solutions, Inc.$186.77
Grifols USA, LLC$168.87

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 92% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Mohammad Azam do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Kyathanahally Dinesh Chandra, MD

Pulmonary Disease

19 yrs NPPES
NPI 1003943556
701 UNIVERSITY BLVD E, SUITE 711, Tuscaloosa, AL 35401(205) 345-2255
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,915 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,915

Total received

98

Transactions

16

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$558.29
GlaxoSmithKline, LLC.$338.43
Grifols USA, LLC$209.82
Boehringer Ingelheim Pharmaceuticals, Inc.$209.68
Regeneron Healthcare Solutions, Inc.$186.77
Amgen Inc.$100.59

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 86th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Kyathanahally Dinesh Chandra do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Tuscaloosa, AL — Verified | DoctorsProof | DoctorsProof